Safety and Tolerability of SYNB8802 in Healthy Adult Volunteers and Adult Subjects With Enteric Hyperoxaluria

NCT04629170 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

77

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy
Enteric Hyperoxaluria

Interventions

DRUG: SYNB8802
DRUG: Placebo

Sponsor

Synlogic